Hostname: page-component-5c6d5d7d68-sv6ng Total loading time: 0 Render date: 2024-08-20T12:05:15.774Z Has data issue: false hasContentIssue false

An Intracranial Leiomyosarcoma in a Child with Neurofibromatosis Type 1

Published online by Cambridge University Press:  02 December 2014

Sumit Jhas
Affiliation:
Department of Surgery, Division of Neurosurgery, The Hospital for Sick Children, The University of Toronto, Toronto, Ontario, Canada
Lowell Henriques
Affiliation:
Department of Surgery, Division of Neurosurgery, The Hospital for Sick Children, The University of Toronto, Toronto, Ontario, Canada
Cynthia Hawkins
Affiliation:
Department of Surgery, Division of Neurosurgery, The Hospital for Sick Children, The University of Toronto, Toronto, Ontario, Canada
Eric Bouffet
Affiliation:
Department of Surgery, Division of Neurosurgery, The Hospital for Sick Children, The University of Toronto, Toronto, Ontario, Canada
James T. Rutka*
Affiliation:
Department of Surgery, Division of Neurosurgery, The Hospital for Sick Children, The University of Toronto, Toronto, Ontario, Canada
*
The Hospital for Sick Children, Department of Surgery, Division of Neurosurgery, Suite 1503, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Communications
Copyright
Copyright © The Canadian Journal of Neurological 2009

References

1. Matsui, I, Tanimura, M, Kobayashi, N, Sawada, T, Nagahara, N, Akatsuka, J. Neurofibromatosis type 1 and childhood cancer. Cancer. 1993 Nov 1;72(9):274654.Google Scholar
2. Xu, GF, O’Connell, P, Viskochil, D, Cawthon, R, Robertson, M, Culver, M, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell. 1990 Aug 10;62(3):599608.Google Scholar
3. Korf, BR. Malignancy in neurofibromatosis type 1. Oncologist. 2000;5(6):47785.CrossRefGoogle ScholarPubMed
4. Cohen, BH, Rothner, AD. Incidence, types, and management of cancer in patients with neurofibromatosis. Oncology (Williston Park). 1989 Sep;3(9):2330; discussion 4, 78.Google Scholar
5. Listernick, R, Charrow, J, Gutmann, DH. Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet. 1999 Mar 26;89(1):3844.Google Scholar
6. Sorensen, SA, Mulvihill, JJ, Nielsen, A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986 Apr 17;314(16):10105.CrossRefGoogle Scholar
7. Bader, JL. Neurofibromatosis and cancer. Ann NY Acad Sci. 1986;486:5765.CrossRefGoogle ScholarPubMed
8. Riccardi, VM. Von Recklinghausen neurofibromatosis. N Engl J Med. 1981 Dec 31;305(27):161727.Google Scholar
9. Side, L, Taylor, B, Cayouette, M, Conner, E, Thompson, P, Luce, M, et al. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med. 1997 Jun 12;336(24):171320.Google Scholar
10. Walther, MM, Herring, J, Enquist, E, Keiser, HR, Linehan, WM. von Recklinghausen’s disease and pheochromocytomas. J Urol. 1999 Nov;162(5):15826.Google Scholar
11. Lewis, RA, Gerson, LP, Axelson, KA, Riccardi, VM, Whitford, RP. von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology. 1984 Aug;91(8):92935.Google Scholar
12. Listernick, R, Charrow, J, Greenwald, M, Mets, M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994 Jul;125(1):636.Google Scholar
13. Pollack, IF, Mulvihill, JJ. Special issues in the management of gliomas in children with neurofibromatosis 1. J Neurooncol. 1996 May-Jun;28(2-3):25768.Google Scholar
14. Bien, E, Stachowicz-Stencel, T, Sierota, D, Polczynska, K, Szolkiewicz, A, Adamkiewicz-Frozynska, E, et al. Sarcomas in children with neurofibromatosis type 1-poor prognosis despite aggressive combined therapy in four patients treated in a single oncological institution. Childs Nerv Syst. 2007 Oct;23(10):114753.Google Scholar
15. Evans, DG, Baser, ME, McGaughran, J, Sharif, S, Howard, E, Moran, A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet. 2002 May;39(5):3114.Google Scholar
16. Paulus, W, Slowik, F, Jellinger, K. Primary intracranial sarcomas: histopathological features of 19 cases. Histopathology. 1991 May;18(5):395402.Google Scholar
17. Hope, DG, Mulvihill, JJ. Malignancy in neurofibromatosis. Adv Neurol. 1981;29:3356.Google Scholar
18. Riccardi, VM. Histogenesis control genes and neurofibromatosis 1. Eur J Pediatr. 2000 Jul;159(7):4756.Google Scholar
19. Lee, TT, Page, LK. Primary cerebral leiomyosarcoma. Clin Neurol Neurosurg. 1997 Aug;99(3):2102.Google Scholar
20. Bernardis, V, Sorrentino, D, Snidero, D, Avellini, C, Paduano, R, Beltrami, CA, et al. Intestinal leiomyosarcoma and gastroparesis associated with von Recklinghausen’s disease. Digestion. 1999 Jan-Feb;60(1):825.Google Scholar
21. Ishizaki, Y, Tada, Y, Ishida, T, Bandai, Y, Idezuki, Y, Hitoshi, N, et al. Leiomyosarcoma of the small intestine associated with von Recklinghausen’s disease: report of a case. Surgery. 1992 Jun;111(6):70610.Google Scholar
22. Kawano, N, Ryu, M, Kinoshita, T, Konishi, M, Iwasak, M, Furuse, J, et al. Segmental resection of the duodenum for treating leiomyosarcoma associated with von Recklinghausen’s disease: a case report. Jpn J Clin Oncol. 1995 Jun;25(3):10912.Google ScholarPubMed
23. Maruta, K, Sonoda, Y, Saigo, R, Yoshioka, T, Fukunaga, H. [A patient with von Recklinghausen’s disease associated with polymyositis, asymptomatic pheochromocytoma, and primary hepatic leiomyosarcoma]. Nippon Ronen Igakkai Zasshi. 2004 May;41(3):33943.Google Scholar
24. Poleksic, S. Leiomyosarcoma of urinary bladder in von Recklinghausen’s neurofibromatosis. Urology. 1977 Oct;10(4):3412.Google Scholar
25. Watanabe, T, Sakamoto, A, Tamiya, S, Oda, Y, Masuda, K, Tsuneyoshi, M. H-ras-1 point mutation in malignant peripheral nerve sheath tumors: polymerase chain reaction restriction fragment length polymorphism analysis and direct sequencing from paraffin-embedded tissues. Int J Mol Med. 2000 Jun;5(6):6058.Google Scholar
26. Bejjani, GK, Stopak, B, Schwartz, A, Santi, R. Primary dural leiomyosarcoma in a patient infected with human immunodeficiency virus: case report. Neurosurgery. 1999 Jan;44(1):199202.CrossRefGoogle Scholar
27. Brown, HG, Burger, PC, Olivi, A, Sills, AK, Barditch-Crovo, PA, Lee, RR. Intracranial leiomyosarcoma in a patient with AIDS. Neuroradiology. 1999 Jan;41(1):359.Google Scholar
28. Eckhardt, BP, Brandner, S, Zollikofer, CL, Wentz, KU. Primary cerebral leiomyosarcoma in a child. Pediatr Radiol. 2004 Jun;34(6):4958.Google Scholar
29. Hussain, S, Nanda, A, Fowler, M, Ampil, FL, Burton, GV. Primary intracranial leiomyosarcoma: report of a case and review of the literature. Sarcoma. 2006;2006:52140.Google Scholar
30. Van Leeuwen, FE, Travis, LB. Second Cancers. In: De Vita, VT, Hellman, S, Rosenberg, S, editors. Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia: Lilppincott Williams and Wilkins; 2005. p. 2575602.Google Scholar
31. Travis, LB, Curtis, RE, Glimelius, B, Holowaty, EJ, Van Leeuwen, FE, Lynch, CF. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin’s lymphoma. JNCI. 1995;87:524.CrossRefGoogle ScholarPubMed
32. Hawkins, MM, Wilson, LM, Burton, HS, Potok, MH, Winter, DL, Marsden, HB, et al. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst. 1996;88:270.CrossRefGoogle ScholarPubMed
33. Travis, LB, Hill, DA, Dores, GM, Gospodarowics, M, Van Leeuwen, FE, Holowaty, E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290:465.Google Scholar
34. Sharif, S, Ferner, R, Birch, JM, Gillespie, JE, Gattarnaneni, HR, Baser, E, et al. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol. 2006 Jun 1;24(16):25705.Google Scholar